Northern Trust’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.22M Sell
462,585
-5,472
-1% -$49.9K ﹤0.01% 2556
2025
Q1
$3.72M Sell
468,057
-56,363
-11% -$448K ﹤0.01% 2579
2024
Q4
$2.85M Buy
524,420
+29,560
+6% +$161K ﹤0.01% 2823
2024
Q3
$3.57M Buy
494,860
+4,335
+0.9% +$31.3K ﹤0.01% 2677
2024
Q2
$5.33M Sell
490,525
-35,808
-7% -$389K ﹤0.01% 2358
2024
Q1
$9.86M Sell
526,333
-16,323
-3% -$306K ﹤0.01% 2050
2023
Q4
$11.8M Sell
542,656
-87,122
-14% -$1.89M ﹤0.01% 1954
2023
Q3
$13M Sell
629,778
-5,525
-0.9% -$114K ﹤0.01% 1829
2023
Q2
$29.9M Buy
635,303
+39,871
+7% +$1.87M 0.01% 1316
2023
Q1
$25M Sell
595,432
-10,393
-2% -$436K 0.01% 1409
2022
Q4
$23.1M Sell
605,825
-391
-0.1% -$14.9K ﹤0.01% 1439
2022
Q3
$23.7M Buy
606,216
+2,257
+0.4% +$88.4K 0.01% 1347
2022
Q2
$19.5M Buy
603,959
+341,525
+130% +$11M ﹤0.01% 1541
2022
Q1
$8.69M Sell
262,434
-7,879
-3% -$261K ﹤0.01% 2235
2021
Q4
$11.5M Buy
270,313
+1,307
+0.5% +$55.6K ﹤0.01% 2134
2021
Q3
$11.9M Sell
269,006
-5,595
-2% -$248K ﹤0.01% 2154
2021
Q2
$15.6M Sell
274,601
-4,489
-2% -$255K ﹤0.01% 2064
2021
Q1
$20.9M Sell
279,090
-12,740
-4% -$954K ﹤0.01% 1798
2020
Q4
$25.2M Sell
291,830
-7,607
-3% -$658K ﹤0.01% 1631
2020
Q3
$18.3M Sell
299,437
-5,985
-2% -$366K ﹤0.01% 1705
2020
Q2
$12.7M Buy
305,422
+42,652
+16% +$1.77M ﹤0.01% 1954
2020
Q1
$7.55M Buy
262,770
+11,643
+5% +$334K ﹤0.01% 2061
2019
Q4
$18.1M Sell
251,127
-32,961
-12% -$2.38M ﹤0.01% 1798
2019
Q3
$39.9M Buy
284,088
+9,468
+3% +$1.33M 0.01% 1146
2019
Q2
$50.3M Buy
274,620
+15,119
+6% +$2.77M 0.01% 994
2019
Q1
$41.3M Buy
259,501
+39,325
+18% +$6.25M 0.01% 1116
2018
Q4
$21.1M Sell
220,176
-173
-0.1% -$16.6K 0.01% 1535
2018
Q3
$31.1M Sell
220,349
-1,627
-0.7% -$230K 0.01% 1421
2018
Q2
$34.7M Sell
221,976
-271,619
-55% -$42.5M 0.01% 1324
2018
Q1
$79.5M Buy
493,595
+49,437
+11% +$7.96M 0.02% 661
2017
Q4
$73.2M Buy
444,158
+31,984
+8% +$5.27M 0.02% 722
2017
Q3
$25.7M Buy
412,174
+730
+0.2% +$45.5K 0.01% 1530
2017
Q2
$32.8M Buy
411,444
+62,474
+18% +$4.98M 0.01% 1288
2017
Q1
$24.8M Buy
348,970
+7,436
+2% +$528K 0.01% 1490
2016
Q4
$17.4M Buy
341,534
+35,536
+12% +$1.81M 0.01% 1697
2016
Q3
$14.1M Buy
305,998
+22,201
+8% +$1.02M ﹤0.01% 1838
2016
Q2
$8.55M Buy
283,797
+101,574
+56% +$3.06M ﹤0.01% 2119
2016
Q1
$5.84M Buy
182,223
+30,538
+20% +$979K ﹤0.01% 2315
2015
Q4
$8.84M Buy
151,685
+6,414
+4% +$374K ﹤0.01% 2097
2015
Q3
$6.15M Buy
145,271
+63,928
+79% +$2.71M ﹤0.01% 2321
2015
Q2
$5.94M Buy
81,343
+19,749
+32% +$1.44M ﹤0.01% 2417
2015
Q1
$3.09M Buy
61,594
+2,979
+5% +$150K ﹤0.01% 2830
2014
Q4
$2.15M Buy
58,615
+44,704
+321% +$1.64M ﹤0.01% 3058
2014
Q3
$439K Buy
+13,911
New +$439K ﹤0.01% 3600